Risk of non-Hodgkin's lymphoma following tuberculosis

Por Askling, J, Ekbom, A
Publicado em 2001

Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis

Por Björnådal, L, Brandt, L, Klareskog, L, Askling, J
Publicado em 2006

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

Por Knight, A, Askling, J, Granath, F, Sparen, P, Ekbom, A
Publicado em 2004

Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case–control study

Por Askling, J, Klareskog, L, Blomqvist, P, Fored, M, Feltelius, N
Publicado em 2006

Do steroids increase lymphoma risk? A case–control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

Por Askling, J, Klareskog, L, Hjalgrim, H, Baecklund, E, Bjorkholm, M, Ekbom, A
Publicado em 2005

Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001

Por Hildebrand, H, Finkel, Y, Grahnquist, L, Lindholm, J, Ekbom, A, Askling, J
Publicado em 2003

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

Por Smedby, K E, Åkerman, M, Hildebrand, H, Glimelius, B, Ekbom, A, Askling, J
Publicado em 2005

Risk of haematopoietic cancer in patients with inflammatory bowel disease

Por Askling, J, Brandt, L, Lapidus, A, Karlén, P, Björkholm, M, Löfberg, R, Ekbom, A
Publicado em 2005

Swedish registers to examine drug safety and clinical issues in RA

Por Askling, J, Fored, C M, Geborek, P, Jacobsson, L T H, van Vollenhoven, R, Feltelius, N, Lindblad, S, Klareskog, L
Publicado em 2006

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

Por Neovius, M, Arkema, E V, Olsson, H, Eriksson, J K, Kristensen, L E, Simard, J F, Askling, J
Publicado no Ann Rheum Dis (2015)

Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study

Por Ludvigsson, J. F., Büsch, K., Olén, O., Askling, J., Smedby, K. E., Ekbom, A., Lindberg, E., Neovius, M.
Publicado no BMC Gastroenterol (2017)

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

Por Olén, O, Askling, J, Sachs, MC, Frumento, P, Neovius, M, Smedby, KE, Ekbom, A, Malmborg, P, Ludvigsson, JF
Publicado no BMJ (2017)

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

Por Simon, T A, Smitten, A L, Franklin, J, Askling, J, Lacaille, D, Wolfe, F, Hochberg, M C, Qi, K, Suissa, S
Publicado em 2009

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Por Askling, J, Fored, C, Brandt, L, Baecklund, E, Bertilsson, L, Feltelius, N, Coster, L, Geborek, P, Jacobsson, L, Lindblad, S, Lysholm, J, Rantapaa-Dahlqvis..., S, Saxne, T, Klareskog, L
Publicado em 2005

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Por Askling, J, Fored, C, Baecklund, E, Brandt, L, Backlin, C, Ekbom, A, Sundstrom, C, Bertilsson, L, Coster, L, Geborek, P, Jacobsson, L, Lindblad, S, Lysholm, J, Rantapaa-Dahlqvis..., S, Saxne, T, Klareskog, L, Feltelius, N
Publicado em 2005